MAPRE1 (EB1), also identified by proteomics analysis, is controlled by c-Myc, RhoA, and CDC42, all of which are linked to HCC malignancy, and shows prognostic prediction value for HCC [21]. The gene discussed is MAPRE1; the disease is hepatocellular carcinoma.